The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1581
ISSUE1581
September 23, 2019
In Brief: Ezallor Sprinkle - A New Formulation of Rosuvastatin
Download PDF: US English
Med Lett Drugs Ther. 2019 Sep 23;61(1581):152
Disclosures
Objective(s)
The lipid-lowering drug rosuvastatin is now available in a sprinkle capsule formulation (Ezallor Sprinkle – Sun Pharma). Rosuvastatin tablets (Crestor, and generics) have been available since 2003.1,2
The new formulation is being marketed specifically for residents of long-term care facilities who have difficulty swallowing. Ezallor Sprinkle capsules can be swallowed whole or opened and their contents sprinkled over applesauce or mixed with water for administration via nasogastric tube.
For those long-term care residents who still have a reasonable indication for a statin but have difficulty swallowing whole tablets, crushing generic rosuvastatin tablets would be a much less expensive option.
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
Previous article